Last $8.26 USD
Change Today +0.12 / 1.47%
Volume 1.3M
PDLI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:10 PM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Samuel E. Broder M.D., Ph.D.

Former Director, Chairman of Scientific Review Committee, Member of Nominating & Governance Committee and Member of Compliance Committee, PDL BioPharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 39 board members in 4 different organizations across 8 different industries.

See Board Relationships
68--

Background*

Dr. Samuel E. Broder, M.D., Ph.D., known as Sam, served as an Executive Vice President of Scientific & Public Affairs at Intrexon Corporation since March 2014 and served as its Chairman of the Health Sector from January 6, 2014 to March 2014. Dr. Broder served as Senior Vice President of Health Sector at Intrexon Corporation until January 6, 2014. He has more than 30 years of internal medicine and oncology experience. He served as the Chief Medical Officer and Vice President ...

Read Full Background

Corporate Headquarters*

932 Southwood Boulevard
Incline Village, Nevada 89451

United States

Phone: 775-832-8500
Fax: 775-832-8501

Board Members Memberships*

Director
2005-2007
Former Director, Chairman of Scientific Review Committee, Member of Nominating & Governance Committee and Member of Compliance Committee
2011-N/A
Former Director
2011-Present
Director
2014-Present
Director and Member of Scientific Advisory Board

Education*

Bachelor's Degree
University of Michigan
MD 1970
University of Michigan

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PDLI:US $8.26 USD +0.12

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John W. Varian Chief Executive Officer, President and Director
XOMA Corporation
$489.3K
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
kr735.0K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr10.7M
Tim Van Hauwermeiren MSc, EMBAChief Executive Officer and Director of Management Board
arGEN-X N.V
€256.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PDL BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.